24 related articles for article (PubMed ID: 21549035)
1. Quantitative determination of latrunculins A and B in the Red Sea sponge Negombata magnifica by high performance liquid chromatography.
Khalifa S; Ahmed S; Mesbah M; Youssef D; Hamann M
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):47-51. PubMed ID: 16431167
[TBL] [Abstract][Full Text] [Related]
2. Method development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection.
Tan KL; Ankathil R; Gan SH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3583-91. PubMed ID: 22000961
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification of dasatinib, nilotinib, bosutinib, and ponatinib using high-performance liquid chromatography-Photodiode array detection.
Yokoyama Y; Nozawa E; Morita M; Ishikawa E; Mori T; Sakurai M; Kikuchi T; Matsuki E; Yamazaki R; Kataoka K; Jibiki A; Kawazoe H; Suzuki S; Nakamura T
J Clin Lab Anal; 2022 Aug; 36(8):e24598. PubMed ID: 35819095
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia.
Fujioka Y; Sugiyama D; Matsumura I; Minami Y; Miura M; Atsuta Y; Ohtake S; Kiyoi H; Miyazaki Y; Nishikawa H; Takahashi N
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885012
[TBL] [Abstract][Full Text] [Related]
5. Towards point of care systems for the therapeutic drug monitoring of imatinib.
Pearce CM; Resmini M
Anal Bioanal Chem; 2020 Sep; 412(24):5925-5933. PubMed ID: 32166445
[TBL] [Abstract][Full Text] [Related]
6. c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism.
Zhou Y; Yamamura Y; Ogawa M; Tsuji R; Tsuchiya K; Kasahara J; Goto S
Front Pharmacol; 2018; 9():1311. PubMed ID: 30505273
[TBL] [Abstract][Full Text] [Related]
7. A quantitative method for the determination of bosutinib in human plasma using high-performance liquid chromatography and ultraviolet detection.
Sumimoto T; Nakahara R; Sato Y; Itoh H
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374910
[TBL] [Abstract][Full Text] [Related]
8. Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays.
Rezende VM; Rivellis A; Novaes MM; de Alencar Fisher Chamone D; Bendit I
Drug Des Devel Ther; 2013; 7():699-710. PubMed ID: 23946646
[TBL] [Abstract][Full Text] [Related]
9. Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance.
Rezende VM; Rivellis AJ; Gomes MM; Dörr FA; Novaes MM; Nardinelli L; Costa AL; Chamone DA; Bendit I
Rev Bras Hematol Hemoter; 2013; 35(2):103-8. PubMed ID: 23741187
[TBL] [Abstract][Full Text] [Related]
10. A multicenter clinical study evaluating the confirmed complete molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction.
Shinohara Y; Takahashi N; Nishiwaki K; Hino M; Kashimura M; Wakita H; Hatano Y; Hirasawa A; Nakagawa Y; Itoh K; Masuoka H; Aotsuka N; Matsuura Y; Takahara S; Sano K; Kuroki J; Hata T; Nakamae H; Mugitani A; Nakane T; Miyazaki Y; Niioka T; Miura M; Sawada K
Haematologica; 2013 Sep; 98(9):1407-13. PubMed ID: 23716542
[TBL] [Abstract][Full Text] [Related]
11. LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma.
Zhang Y; Qiang S; Yu Z; Zhang W; Xu Z; Yang L; Wen A; Hang T
J Chromatogr Sci; 2014 Apr; 52(4):344-50. PubMed ID: 23574742
[TBL] [Abstract][Full Text] [Related]
12. Validation of an HPLC method for determination of imatinib mesylate in rat serum and its application in a pharmacokinetic study.
Bende G; Kollipara S; Movva S; Moorthy G; Saha R
J Chromatogr Sci; 2010; 48(5):334-41. PubMed ID: 20515524
[TBL] [Abstract][Full Text] [Related]
13. Determination of fexofenadine enantiomers in human plasma with high-performance liquid chromatography.
Miura M; Uno T; Tateishi T; Suzuki T
J Pharm Biomed Anal; 2007 Jan; 43(2):741-5. PubMed ID: 16934428
[TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of imatinib in human plasma with high-performance liquid chromatography and ultraviolet detection.
Miura M; Takahashi N; Sawada K
J Chromatogr Sci; 2011 May; 49(5):412-5. PubMed ID: 21549035
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatography with solid-phase extraction for the quantitative determination of nilotinib in human plasma.
Miura M; Takahashi N; Sawada K
Biomed Chromatogr; 2010 Jul; 24(7):789-93. PubMed ID: 19904720
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry.
Kralj E; Trontelj J; Pajič T; Kristl A
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():150-6. PubMed ID: 22857863
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]